表紙:術中照射療法 (IORT) の世界市場 (~2025年):技術 (エレクトロンIORT・術中小線源療法)・製品&サービス (アクセラレーター・治療計画システム・アプリケーター・アフターローダー・付属品)・用途 (乳癌・脳腫瘍・肺癌)・地域別
市場調査レポート
商品コード
990221

術中照射療法 (IORT) の世界市場 (~2025年):技術 (エレクトロンIORT・術中小線源療法)・製品&サービス (アクセラレーター・治療計画システム・アプリケーター・アフターローダー・付属品)・用途 (乳癌・脳腫瘍・肺癌)・地域別

Intraoperative Radiation Therapy Market by Technology (Electron IORT, Brachytherapy), Products & Services (Accelerators, Treatment Planning system, Applicators, Afterloaders, Accessories), Application(Breast, Brain, Lung Cancer)-Global Forecasts to 2025

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 156 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
術中照射療法 (IORT) の世界市場 (~2025年):技術 (エレクトロンIORT・術中小線源療法)・製品&サービス (アクセラレーター・治療計画システム・アプリケーター・アフターローダー・付属品)・用途 (乳癌・脳腫瘍・肺癌)・地域別
出版日: 2021年02月15日
発行: MarketsandMarkets
ページ情報: 英文 156 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の術中照射療法 (IORT) の市場規模は予測期間中6.4%のCAGRで推移し、2020年の4800万米ドルから、2025年には6600万米ドルの規模に成長すると予測されています。

癌の発生率の上昇、技術の進歩、従来の放射線療法に勝るIORTの利点などの要因が同市場の成長を推進しています。また、さまざまな癌へのIORT利用を検討する臨床試験の拡大も参入事業者に有利な成長機会を示しています。一方で、技術の複雑さ、訓練を受けた人材の不足、償還の限定性から医師が従来法を選ぶ傾向などの課題が市場のさらなる成長の妨げとなっています。

製品タイプ別で見ると、システム・アクセラレーターの部門が予測期間中に最大のシェアを示すと予測されています。先進的な放射線手術製品と比較してアクセラレーターのコストが低いこと、癌治療におけるIORT製品の用途が拡大していること、先進的な製品の開発などの要因が同部門の成長を牽引しています。

当レポートでは、世界の術中照射療法 (IORT) の市場を調査し、市場の定義と概要、バリューチェーン、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、市場規模の推移・予測、製品&サービス材料・技術・用途・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • COVID-19の影響
  • 世界の規制シナリオ
  • バリューチェーン
  • エコシステム

第6章 市場分析・予測:製品・サービス別

  • IORT製品
    • システム・アクセラレーター
    • アプリケーター・アフターローダー
    • 治療計画システム
    • 付属品
  • IORTサービス

第7章 市場分析・予測:技術別

  • エレクトロンIORT
  • 術中小線源治療

第8章 市場分析・予測:用途別

  • 乳癌
  • 脳腫瘍
  • 消化器癌
  • 頭頸部癌
  • 結腸直腸癌
  • 子宮内膜癌・子宮頸癌
  • 肺癌
  • その他

第9章 市場分析・予測:地域・主要国別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 市場シェア分析
  • 主な市場展開

第11章 企業評価マトリックス・企業プロファイル

  • 競合マトリックス
  • 企業プロファイル
    • ZEISS GROUP
    • ICAD, INC.
    • ECKERT & ZIEGLER
    • ARIANE MEDICAL SYSTEMS LTD.
    • BECTON, DICKINSON AND COMPANY
    • ELEKTA AB
    • GMV INNOVATING SOLUTIONS
    • INTRAOP MEDICAL, INC.
    • ISOAID, LLC
    • ISORAY, INC.
    • PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
    • SEEDOS LTD.
    • SENSUS HEALTHCARE, INC.
    • S.I.T. SORDINA IORT TECHNOLOGIES S.P.A.
    • VARIAN MEDICAL SYSTEMS, INC.
    • その他の企業

第12章 付録

目次
Product Code: MD 7339

The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period. The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players. However, the complex nature of technology coupled with a shortage of trained personnel and preference of conventional radiotherapy over IORT by physicians owing to reimbursement coverage are the major factors that are expected to restrain the growth of this market.

"The system/accelerators segment is expected to account for the largest market share during the forecast period."

Based on product type, the intraoperative radiation therapy market products market is segmented into system/accelerators, treatment planning systems, applicators & afterloaders, and accessories. The systems/accelerators segment is expected to account for the largest share of the IORT products market in 2019. The large share of this segment can be attributed to the low cost of accelerators as compared to advanced radiosurgery products, growing applications of IORT products in cancer treatment, and the development of technologically advanced mobile systems/accelerators.

"The breast cancer segment is expected to hold the largest share of the intraoperative radiation therapy market, by application, during the forecast period."

Based on application, the intraoperative radiation therapy market is segmented into breast cancer, brain tumor, gastrointestinal cancer, head and neck cancer, colorectal cancer, endometrial and cervical cancer, lung cancer, and other cancers. The breast cancer segment is expected to account for the largest share of this market in 2019. The large share of this segment can be attributed to a high prevalence of breast cancer, coupled with advantages offered by IORT such as the reduced amount of irradiation, shorter treatment time, and lesser clinical risks.

"Europe to account for the second-largest share of the global market in 2019."

The intraoperative radiation therapy market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and Middle East and Africa. Europe is expected to account for the second-largest share of the global intraoperative radiation therapy market in 2019. The growing incidence of cancer, supportive government initiatives, and the implementation of intraoperative radiation therapy market training programs & conferences/symposiums are the major factors propelling the demand for intraoperative radiation therapy market products in Europe. Furthermore, several key market players are focusing on enhancing their intraoperative radiation therapy market products to improve the quality of patient care across Europe.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-45%, Tier 2-34%, and Tier 3- 21%
  • By Designation: C-level-47%, Director-level-33%, and Others-20%
  • By Region: North America-35%, Europe-32%, Asia Pacific-25%, Latin America-6%, and the Middle East & Africa-2%

Some of the prominent players in the antimicrobial susceptibility testing market include ZEISS Group (Germany), iCAD, Inc. (US), Eckert & Ziegler (Germany), Elekta AB (Sweden), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc. (US), IntraOp Medical, Inc. (US), Isoray, Inc. (US), Becton, Dickinson and Company (US), Sordina IORT Technologies (Italy), Varian Medical Systems, Inc. (US), SeeDos Ltd. (UK), IsoAid LLC (US), Ariane Medical Systems Ltd. (UK), Panacea Medical Technologies Pvt. Ltd. (India), Salutaris Medical Devices (US), Brainlab AG (Germany), RaySearch Laboratories (Sweden), REMEDI Co., Ltd. (South Korea), Merit Medical Systems, Inc. (US), among others.

Research Coverage

This report studies the IORT market based on product and service, technology, application, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the Intraoperative radiation therapy market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the Intraoperative radiation therapy market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the Intraoperative radiation therapy market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Breakdown of primaries
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: INTRAOPERATIVE RADIATION THERAPY MARKET
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.2 END USER-BASED MARKET ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION: INTRAOPERATIVE RADIATION THERAPY MARKET
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
    • FIGURE 5 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 6 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 7 INTRAOPERATIVE RADIATION THERAPY MARKET SHARE, BY TECHNOLOGY, 2020 VS. 2025
    • FIGURE 8 INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
    • FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE INTRAOPERATIVE RADIATION THERAPY MARKET

4 PREMIUM INSIGHTS

  • 4.1 INTRAOPERATIVE RADIATION THERAPY MARKET OVERVIEW
    • FIGURE 10 GROWING PREVALENCE OF CANCER IS DRIVING THE GROWTH OF THE INTRAOPERATIVE RADIATION THERAPY MARKET
  • 4.2 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 11 IORT PRODUCTS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
  • 4.3 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 12 SYSTEMS & ACCELERATORS SEGMENT WILL CONTINUE TO DOMINATE THE NORTH AMERICAN MARKET IN 2025
  • 4.4 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
    • FIGURE 13 ELECTRON IORT SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE APAC INTRAOPERATIVE RADIATION THERAPY MARKET
  • 4.5 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION & COUNTRY (2019)
    • FIGURE 14 BREAST CANCER SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN INTRAOPERATIVE RADIATION THERAPY MARKET IN 2019
  • 4.6 INTRAOPERATIVE RADIATION THERAPY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 15 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 16 INTRAOPERATIVE RADIATION THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing global prevalence of cancer
      • 5.2.1.2 Improving reimbursement scenario
    • TABLE 1 NATIONAL AVERAGE MEDICARE REIMBURSEMENT CPT CODES, 2019
      • 5.2.1.3 Procedural advantages over EBRT
      • 5.2.1.4 Technological advancements
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Dearth of trained personnel
      • 5.2.2.2 Strong market positioning of alternative therapies
    • TABLE 2 ALTERNATIVES TO IORT PROCEDURES
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging economies offer high growth potential
      • 5.2.3.2 Growing applications of IORT
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Risk of radiation exposure
  • 5.3 IMPACT OF COVID-19 ON THE INTRAOPERATIVE RADIATION THERAPY MARKET
  • 5.4 GLOBAL REGULATORY SCENARIO
    • 5.4.1 NORTH AMERICA
      • 5.4.1.1 US
    • TABLE 3 US: MEDICAL DEVICE CLASSIFICATION
    • TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.4.1.2 Canada
    • TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • FIGURE 17 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
    • 5.4.2 EUROPE
    • FIGURE 18 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
    • 5.4.3 ASIA PACIFIC
      • 5.4.3.1 Japan
    • TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.4.3.2 China
    • TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.4.3.3 India
  • 5.5 VALUE CHAIN ANALYSIS: GLOBAL INTRAOPERATIVE RADIATION THERAPY MARKET
    • FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING THE MANUFACTURING PHASE
  • 5.6 ECOSYSTEM COVERAGE: GLOBAL RADIOTHERAPY MARKET

6 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 8 INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • 6.2 IORT PRODUCTS
    • TABLE 9 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 10 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • 6.2.1 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TECHNOLOGY
    • TABLE 11 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 6.2.2 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY APPLICATION
    • TABLE 12 INTRAOPERATIVE RADIATION THERAPY PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 6.2.3 SYSTEMS & ACCELERATORS
      • 6.2.3.1 Affordability of systems & accelerators is supporting their adoption
    • TABLE 13 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SYSTEMS & ACCELERATORS, BY REGION, 2018-2025 (USD MILLION)
      • 6.2.3.2 Intraoperative radiation therapy market for systems & accelerators, by technology
    • TABLE 14 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SYSTEMS & ACCELERATORS, BY TECHNOLOGY, 2018-2025 (USD MILLION)
      • 6.2.3.3 Intraoperative radiation therapy market for systems & accelerators, by application
    • TABLE 15 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SYSTEMS & ACCELERATORS, BY APPLICATION, 2018-2025 (USD MILLION)
    • 6.2.4 APPLICATORS & AFTERLOADERS
      • 6.2.4.1 Growing approvals of applicators & afterloaders for the treatment of different cancer types is supporting the growth of this segment
    • TABLE 16 INTRAOPERATIVE RADIATION THERAPY MARKET FOR APPLICATORS & AFTERLOADERS, BY REGION, 2018-2025 (USD MILLION)
      • 6.2.4.2 Intraoperative radiation therapy market for applicators & afterloaders, by technology
    • TABLE 17 INTRAOPERATIVE RADIATION THERAPY MARKET FOR APPLICATORS & AFTERLOADERS, BY TECHNOLOGY, 2018-2025 (USD MILLION)
      • 6.2.4.3 Intraoperative radiation therapy market for applicators & afterloaders, by application
    • TABLE 18 INTRAOPERATIVE RADIATION THERAPY MARKET FOR APPLICATORS & AFTERLOADERS, BY APPLICATION, 2018-2025 (USD MILLION)
    • 6.2.5 TREATMENT PLANNING SYSTEMS
      • 6.2.5.1 Technological advancements & growing regulatory approvals are supporting market growth
    • TABLE 19 INTRAOPERATIVE RADIATION THERAPY MARKET FOR TREATMENT PLANNING SYSTEMS, BY REGION, 2018-2025 (USD MILLION)
      • 6.2.5.2 Intraoperative radiation therapy market for treatment planning systems, by technology
    • TABLE 20 INTRAOPERATIVE RADIATION THERAPY MARKET FOR TREATMENT PLANNING SYSTEMS, BY TECHNOLOGY, 2018-2025 (USD MILLION)
      • 6.2.5.3 Intraoperative radiation therapy market for treatment planning systems, by application
    • TABLE 21 INTRAOPERATIVE RADIATION THERAPY MARKET FOR TREATMENT PLANNING SYSTEMS, BY APPLICATION, 2018-2025 (USD MILLION)
    • 6.2.6 ACCESSORIES
      • 6.2.6.1 Growing number of IORT procedures to drive the adoption of IORT accessories
    • TABLE 22 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ACCESSORIES, BY REGION, 2018-2025 (USD MILLION)
      • 6.2.6.2 Intraoperative radiation therapy market for accessories, by technology
    • TABLE 23 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ACCESSORIES, BY TECHNOLOGY, 2018-2025 (USD MILLION)
      • 6.2.6.3 Intraoperative radiation therapy market for accessories, by application
    • TABLE 24 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ACCESSORIES, BY APPLICATION, 2018-2025 (USD MILLION)
  • 6.3 IORT SERVICES
    • 6.3.1 NEED FOR FREQUENT SOFTWARE UPGRADES TO DRIVE MARKET GROWTH
    • TABLE 25 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY REGION, 2018-2025 (USD MILLION)
    • 6.3.2 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY TECHNOLOGY
    • TABLE 26 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • 6.3.3 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY APPLICATION
    • TABLE 27 INTRAOPERATIVE RADIATION THERAPY MARKET FOR SERVICES, BY APPLICATION, 2018-2025 (USD MILLION)

7 INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 28 INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • 7.2 ELECTRON IORT
    • 7.2.1 MINIMAL TREATMENT TIME OF THIS PROCEDURE HAS INCREASED ITS ADOPTION IN THE MARKET
    • TABLE 29 PROMISING CLINICAL TRIALS FOR ELECTRON IORT
    • TABLE 30 ELECTRON IORT MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 7.3 INTRAOPERATIVE BRACHYTHERAPY
    • 7.3.1 LOWER COST THAN IOERT & BETTER DOSIMETRIC DISTRIBUTION ARE THE KEY FACTORS SUPPORTING MARKET GROWTH
    • TABLE 31 INTRAOPERATIVE BRACHYTHERAPY MARKET, BY REGION, 2018-2025 (USD MILLION)

8 INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 32 INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 8.2 BREAST CANCER
    • 8.2.1 GROWING NUMBER OF BREAST CANCER CASES ACROSS THE GLOBE IS FUELING THE ADOPTION OF IORT
    • TABLE 33 INTRAOPERATIVE RADIATION THERAPY MARKET FOR BREAST CANCER, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 BRAIN TUMOR
    • 8.3.1 GROWING NUMBER OF BRAIN TUMOR CASES TO DRIVE MARKET GROWTH
    • TABLE 34 INTRAOPERATIVE RADIATION THERAPY MARKET FOR BRAIN TUMOR, BY REGION, 2018-2025 (USD MILLION)
  • 8.4 GASTROINTESTINAL CANCER
    • 8.4.1 IORT OFFERS A SUITABLE ALTERNATIVE FOR GASTROINTESTINAL CANCER TREATMENT AS OPPOSED TO SURGERY OR CONVENTIONAL RADIATION
    • TABLE 35 INTRAOPERATIVE RADIATION THERAPY MARKET FOR GASTROINTESTINAL CANCER, BY REGION, 2018-2025 (USD MILLION)
  • 8.5 HEAD & NECK CANCER
    • 8.5.1 IORT IS HIGHLY EFFICIENT IN THE TREATMENT OF HEAD & NECK CANCER AS IT OFFERS BETTER TUMOR CONTROL
    • TABLE 36 INTRAOPERATIVE RADIATION THERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2018-2025 (USD MILLION)
  • 8.6 COLORECTAL CANCER
    • 8.6.1 IORT IS PROVEN EFFECTIVE FOR ADVANCED LOCAL AND RECURRENT COLORECTAL CANCER TREATMENT IN COMBINATION WITH PREOPERATIVE EBRT
    • TABLE 37 INTRAOPERATIVE RADIATION THERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2018-2025 (USD MILLION)
  • 8.7 ENDOMETRIAL & CERVICAL CANCER
    • 8.7.1 IORT IN COMBINATION WITH RADICAL RESECTION PROCEDURES IS A CURATIVE OPTION FOR PATIENTS WITH RECURRENT ENDOMETRIAL CANCER
    • TABLE 38 INTRAOPERATIVE RADIATION THERAPY MARKET FOR ENDOMETRIAL & CERVICAL CANCER, BY REGION, 2018-2025 (USD MILLION)
  • 8.8 LUNG CANCER
    • 8.8.1 ALTERNATIVE TREATMENT OPTIONS FOR LUNG CANCER IS EXPECTED TO HAMPER THE GROWTH OF THIS SEGMENT
    • TABLE 39 INTRAOPERATIVE RADIATION THERAPY MARKET FOR LUNG CANCER, BY REGION, 2018-2025 (USD MILLION)
  • 8.9 OTHER CANCERS
    • TABLE 40 INTRAOPERATIVE RADIATION THERAPY MARKET FOR OTHER CANCERS, BY REGION, 2018-2025 (USD MILLION)

9 INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 41 INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 20 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET SNAPSHOT
    • TABLE 42 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 43 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 44 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 45 NORTH AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 Higher adoption rate of innovative technologies to support market growth in the US
    • TABLE 46 US: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Surge in the incidence of cancer and favorable government guidelines to support the market growth
    • TABLE 47 CANADA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 48 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 49 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 50 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 51 EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Growing awareness about advanced cancer treatment is expected to fuel the adoption of IORT products in Germany
    • TABLE 52 GERMANY: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Initiatives by public & private organizations to increase awareness about IORT
    • TABLE 53 UK: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Preference for conventional radiotherapy is restraining the growth of the IORT market in France
    • TABLE 54 FRANCE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • 9.3.4 SPAIN
      • 9.3.4.1 Growing geriatric population to support market growth
    • TABLE 55 SPAIN: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • 9.3.5 ITALY
      • 9.3.5.1 Rising awareness activities to support market growth
    • TABLE 56 ITALY: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 57 REST OF EUROPE: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 21 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET SNAPSHOT
    • TABLE 58 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 59 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 60 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 61 ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 Increasing patient pool and government initiatives for healthcare development are fueling the market growth
    • TABLE 62 CHINA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Presence of universal healthcare reimbursement scenario and rising breast cancer cases-key factors driving market growth
    • TABLE 63 JAPAN: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Government initiatives to improve cancer treatment to drive market growth in India
    • TABLE 64 INDIA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • 9.4.4 SOUTH KOREA
      • 9.4.4.1 Rising R&D and promising clinical trials in the country to positively impact market growth
    • TABLE 65 SOUTH KOREA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Rising research investments and awareness campaigns are the key factors supporting market growth
    • TABLE 66 AUSTRALIA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • 9.4.6 REST OF ASIA PACIFIC
    • TABLE 67 REST OF ASIA PACIFIC: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • 9.5 LATIN AMERICA
    • TABLE 68 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 69 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 70 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 71 LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • 9.5.1 BRAZIL
      • 9.5.1.1 Brazil is a key market in Latin America owing to the modernization of healthcare facilities
    • TABLE 72 BRAZIL: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • 9.5.2 MEXICO
      • 9.5.2.1 Availability of advanced care and increasing awareness programs are fueling market growth in Mexico
    • TABLE 73 MEXICO: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • 9.5.3 REST OF LATIN AMERICA
    • TABLE 74 REST OF LATIN AMERICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA
    • TABLE 75 MIDDLE EAST & AFRICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 76 MIDDLE EAST & AFRICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 77 MIDDLE EAST & AFRICA: INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • FIGURE 22 KEY DEVELOPMENTS IN THE INTRAOPERATIVE RADIATION THERAPY MARKET FROM 2017 TO 2020
  • 10.2 MARKET SHARE ANALYSIS
    • FIGURE 23 INTRAOPERATIVE RADIATION THERAPY MARKET SHARE, BY KEY PLAYER, 2019
  • 10.3 KEY MARKET DEVELOPMENTS
    • 10.3.1 PRODUCT LAUNCHES & APPROVALS
    • 10.3.2 ACQUISITIONS
    • 10.3.3 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
    • 10.3.4 EXPANSIONS

11 COMPANY EVOLUTION MATRIX AND COMPANY PROFILES

  • 11.1 COMPETITIVE EVALUATION MATRIX AND METHODOLOGY
    • 11.1.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2019)
    • 11.1.2 STARS
    • 11.1.3 EMERGING LEADERS
    • 11.1.4 EMERGING COMPANIES
    • 11.1.5 PERVASIVE
    • FIGURE 24 COMPETITIVE LEADERSHIP MAPPING: OVERALL MARKET (2019)
    • FIGURE 25 COMPETITIVE LEADERSHIP MAPPING: EMERGING PLAYERS (2019)
  • 11.2 COMPANY PROFILES
  • (Business overview, Products offered, Recent developments, MNM view)**
    • 11.2.1 ZEISS GROUP
    • FIGURE 26 ZEISS GROUP: COMPANY SNAPSHOT (2019)
    • 11.2.2 ICAD, INC.
    • FIGURE 27 ICAD, INC.: COMPANY SNAPSHOT (2019)
    • 11.2.3 ECKERT & ZIEGLER
    • FIGURE 28 ECKERT & ZIEGLER: COMPANY SNAPSHOT (2019)
    • 11.2.4 ARIANE MEDICAL SYSTEMS LTD.
    • 11.2.5 BECTON, DICKINSON AND COMPANY
    • FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
    • 11.2.6 ELEKTA AB
    • FIGURE 30 ELEKTA AB: COMPANY SNAPSHOT (2019)
    • 11.2.7 GMV INNOVATING SOLUTIONS
    • 11.2.8 INTRAOP MEDICAL, INC.
    • 11.2.9 ISOAID, LLC
    • 11.2.10 ISORAY, INC.
    • FIGURE 31 ISORAY, INC.: COMPANY SNAPSHOT (2019)
    • 11.2.11 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
    • 11.2.12 SEEDOS LTD.
    • 11.2.13 SENSUS HEALTHCARE, INC.
    • FIGURE 32 SENSUS HEALTHCARE, INC.: COMPANY SNAPSHOT (2019)
    • 11.2.14 S.I.T. SORDINA IORT TECHNOLOGIES S.P.A.
    • 11.2.15 VARIAN MEDICAL SYSTEMS, INC.
    • FIGURE 33 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2019)
  • *Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
    • 11.2.16 OTHER COMPANIES
      • 11.2.16.1 Salutaris Medical Devices
      • 11.2.16.2 Brainlab AG
      • 11.2.16.3 RaySearch Laboratories
      • 11.2.16.4 REMEDI Co., Ltd.
      • 11.2.16.5 Merit Medical Systems

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS